{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:23:47Z","timestamp":1781511827562,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ando.2020.11.008","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T10:44:13Z","timestamp":1607165053000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expression of ARID1A in polycystic ovary syndrome and its effect on the proliferation and apoptosis of ovarian granulosa cells"],"prefix":"10.1016","volume":"81","author":[{"given":"Xiao-Ling","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2020.11.008_bib0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2020.11.008_bib0190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/138161212799040457","article-title":"Phenotypes and enviromental factors: their influence in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ando.2020.11.008_bib0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11920-017-0834-2","article-title":"Depression and anxiety in polycystic ovary syndrome: etiology and treatment","volume":"19","author":"Cooney","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.ando.2020.11.008_bib0200","doi-asserted-by":"crossref","first-page":"27899","DOI":"10.18632\/oncotarget.8544","article-title":"Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ando.2020.11.008_bib0205","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2007-1650","article-title":"Granulosa cell survival and proliferation are altered in polycystic ovary syndrome","volume":"93","author":"Das","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.11.008_bib0210","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1210\/jc.2015-4275","article-title":"Enhanced inflammatory transcriptome in the granulosa cells of women with polycystic ovarian syndrome","volume":"101","author":"Adams","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.11.008_bib0215","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/gcc.20459","article-title":"Genomic and functional evidence for an ARID1A tumor suppressor role","volume":"46","author":"Huang","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ando.2020.11.008_bib0220","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","article-title":"ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers","volume":"71","author":"Guan","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ando.2020.11.008_bib0225","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ncb3582","article-title":"ARID1A-mutated ovarian cancers depend on HDAC6 activity","volume":"19","author":"Bitler","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ando.2020.11.008_bib0230","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/path.2911","article-title":"Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas","volume":"224","author":"Wiegand","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.ando.2020.11.008_bib0235","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2020.11.008_bib0240","doi-asserted-by":"crossref","first-page":"18824","DOI":"10.3390\/ijms140918824","article-title":"ARID1A mutations and PI3K\/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas","volume":"14","author":"Samartzis","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ando.2020.11.008_bib0245","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/me.2012-1307","article-title":"IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells","volume":"27","author":"Zhou","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ando.2020.11.008_bib0250","first-page":"329","article-title":"Aquatic environment, housing, and management in the eighth edition of the Guide for the Care and Use of Laboratory Animals: additional considerations and recommendations","volume":"51","author":"Mason","year":"2012","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.ando.2020.11.008_bib0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2020.11.008_bib0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/19396368.2017.1296046","article-title":"Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome","volume":"63","author":"Bakhshalizadeh","year":"2017","journal-title":"Syst Biol Reprod Med"},{"key":"10.1016\/j.ando.2020.11.008_bib0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.08.028","article-title":"Leptin siRNA promotes ovarian granulosa cell apoptosis and affects steroidogenesis by increasing NPY2 receptor expression","volume":"633","author":"Ding","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.ando.2020.11.008_bib0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000464351","article-title":"Akt-mTOR signaling mediates abnormalities in the proliferation and apoptosis of ovarian granulosa cells in patients with polycystic ovary syndrome","volume":"83","author":"Song","year":"2018","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ando.2020.11.008_bib0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jsbmb.2015.01.001","article-title":"Leptin exerts proliferative and anti-apoptotic effects on goose granulosa cells through the PI3K\/Akt\/mTOR signaling pathway","volume":"149","author":"Wen","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ando.2020.11.008_bib0280","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.canep.2011.07.006","article-title":"Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance","volume":"36","author":"Zhang","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ando.2020.11.008_bib0285","first-page":"1314","article-title":"Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer","volume":"22","author":"Wang","year":"2017","journal-title":"J BUON"},{"key":"10.1016\/j.ando.2020.11.008_bib0290","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IGC.0000000000000698","article-title":"BAF250a expression in atypical endometriosis and endometriosis-associated ovarian cancer","volume":"26","author":"Stamp","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ando.2020.11.008_bib0295","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/modpathol.2013.96","article-title":"Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations. TP53 and microsatellite instability in endometrial cancer","volume":"26","author":"Bosse","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ando.2020.11.008_bib0300","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/hmbci-2016-0005","article-title":"Hormones and endometrial carcinogenesis","volume":"25","author":"Kamal","year":"2016","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.ando.2020.11.008_bib0305","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2013.35","article-title":"The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium","volume":"26","author":"Fadare","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ando.2020.11.008_bib0310","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1038\/onc.2011.386","article-title":"An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer","volume":"31","author":"Mamo","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ando.2020.11.008_bib0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygyno.2014.04.047","article-title":"MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A","volume":"134","author":"Wang","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ando.2020.11.008_bib0320","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12253-017-0338-8","article-title":"Low Arid1a expression correlates with poor prognosis and promotes cell proliferation and metastasis in osteosarcoma","volume":"25","author":"Xu","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.ando.2020.11.008_bib0325","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.2147\/OTT.S139664","article-title":"AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells","volume":"10","author":"Lee","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ando.2020.11.008_bib0330","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1007\/s13277-014-1755-x","article-title":"ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ando.2020.11.008_bib0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40199-017-0188-7","article-title":"Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K\/AKT pathway","volume":"25","author":"Zhao","year":"2017","journal-title":"Daru"},{"key":"10.1016\/j.ando.2020.11.008_bib0340","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1933719116667606","article-title":"Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome","volume":"24","author":"Li","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ando.2020.11.008_bib0345","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1349-7006.2009.01246.x","article-title":"DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation","volume":"100","author":"Wang","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ando.2020.11.008_bib0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/JEnvironPatholToxicolOncol.v30.i1.30","article-title":"Oleanolic acid induces apoptosis by modulating p53, Bax, Bcl-2 and caspase-3 gene expression and regulates the activation of transcription factors and cytokine profile in B16F","volume":"30","author":"Pratheeshkumar","year":"2011","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"10.1016\/j.ando.2020.11.008_bib0355","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00404-006-0171-x","article-title":"Polycystic ovary syndrome: etiology and pathogenesis","volume":"274","author":"Matalliotakis","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ando.2020.11.008_bib0360","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/des089","article-title":"Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells","volume":"27","author":"Reverchon","year":"2012","journal-title":"Hum Reprod"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620313111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620313111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:52:16Z","timestamp":1757717536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426620313111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0003426620313111"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2020.11.008","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of ARID1A in polycystic ovary syndrome and its effect on the proliferation and apoptosis of ovarian granulosa cells","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}